Image by Clique Images / Stocksy

Jealousy, affectionately known as the green-eyed monster, gets a bad rap when it comes to emotions because it can be disregarded as a “superficial emotion.” While most commonly associated with romantic relationships, jealousy can show up in a professional environment, within friendships, family, and elsewhere. Instead of typecasting jealousy as a “petty” emotion, consider jealousy an opportunity to improve your emotional intelligence by recognizing, understanding, and managing your emotions.

Most people confuse feelings of jealousy with feelings of envy. The difference is, when you experience jealousy, you see a person or thing as an obstacle to you receiving love, attention, affection, etc. As compared to envy, you want to acquire something that another person has. Based on that definition, it is possible that if you’re feeling jealous, this may be an indication of a possible unmet and unsaid emotional need within your relationship.

When encountering feelings of jealousy, your gut reaction may be to shove your feelings to the side or to rush through them because you feel uncomfortable. Unfortunately, doing that is a disservice to yourself. I recommend taking this slow and allowing yourself to process through all the things because every emotion—even jealousy—can be processed more healthily.

Here are four steps to deal with feeling jealous:

1. Admit to yourself that you’re experiencing jealousy.

Let me clear the air by saying this: Admitting that you are jealous does not make you a bad person!

Jealousy is a part of the wide range of emotions that humans will experience at some point in their life. Denying the fact that you are jealous can potentially set you on a cycle of constantly denying your feelings.

Consider for a moment: What are some possible barriers to admitting that you’re jealous?

  • Do you feel that being jealous is not socially acceptable?
  • Is there any sense of shame connected to the feeling of being jealous?
  • Does this trigger feelings of powerlessness about the situation?
  • Does this make you feel like a bad person?

Being honest with yourself about where you are emotionally removes an additional barrier to working through them. When you take a moment to accept what you’re feeling, you get to:

  • Reaffirm to yourself that your thoughts and feelings are all important
  • Remember that your emotions do need time and space for processing at your speed


2. Identify your unsaid and unmet needs.

This part can be uncomfortable because you have to exercise vulnerability within yourself. With jealousy involving a third party, I suggest doing a self-assessment to help you sift through the tangle of emotions. You don’t want to operate on assumptions or find yourself dredging up past experiences and then projecting them onto your current relationship.

The self-assessment can be as simple as asking yourself the following questions:

  • What is the emotion telling me?
  • Where do I feel unseen in this relationship?
  • What am I no longer getting from this relationship that I believe this other person or thing is now getting instead?
  • What do I believe I’m losing?

Answering these questions honestly can reveal unmet needs that you may have not thought about communicating. With this new awareness, you can now decide how you would like to move forward in response to your feelings.

3. Do the repair work with the appropriate person(s).

Be mindful of why, when, and with whom you are sharing your feelings. The last thing you want to do is make things worse by speaking to the person you perceive as the reason you’re potentially losing attention and affection in your relationship.

By instead going to the person you’re in a relationship with and sharing your emotions, you’re building emotional intimacy and connection through vulnerability. Relaying the fact that you feel jealous and want to move past it sheds a light on those unsaid and unmet needs and allows the relationship to improve and heal through your transparency. If you’re out of practice, here’s an example of how you can get the conversation going:

“I want to share with you the emotional space that I’m in, even though it’s uncomfortable to me. I am experiencing a bit of jealousy when I notice [identify the external source and the behavior]. When I see this, I feel [include any additional emotion that you’re experiencing with the jealousy] because [share how it’s affecting you]. I want to be able to [name the changes that you would like to see], and I am hoping that you can help me with this.”

This example takes ownership of your emotions instead of attacking the other person. It identifies additional emotions that may be layered with the jealousy and gives examples of what behaviors trigger the emotion as an observation instead of an accusation. Finally, it gives the partner an opportunity to collaborate on solutions, which reinforces the unit instead of pitting one person against the other.

Note: While this message is a generic response, tone is everything and can change how your message is received.

4. Refrain from making rash decisions.

Choices made during temporary heightened emotions can have long-lasting negative impacts. Jealousy that gets out of control can manifest into envy and anger, which can lead to the relationship corroding, which is the opposite of what you’re wanting. If you’re able to take a moment and self-soothe when you’re in the thick of it, you can decrease the likelihood of making a regretful choice.

Try doing any of the following exercises:

  • Deep breathing exercise
  • Progressive muscle relaxation
  • A mindfulness activity

The bottom line.

If you can see beyond the shallow understanding of jealousy, you may be able to reframe it and see it from the perspective where it can be enlightening and useful in relationships. If processed healthily, jealousy can increase awareness within the relationship, strengthen trust, and build emotional intimacy if all parties involved are committed to personal needs being expressed and met.



Some experts say the data do not support boosters across the board for everyone—at least not yet.

There’s a cloud hanging over the Biden administration’s plan to make COVID-19 booster doses widely available to vaccinated Americans.

In August, US government officials set the wheels in motion to provide an extra dose of the vaccine to those who’ve already received their shots. The proposed plan was tentatively slated to kick off on September 20, pending review by the US Food and Drug Administration (FDA).

Since that announcement, some experts have questioned whether there’s sufficient data to justify administering a booster to all individuals who have completed their initial vaccine series.

In an editorial published in the Lancet on September 13, an international group of scientists advanced the debate, arguing that current evidence does not appear to show a need for boosters across the board. There’s no “credible evidence of substantially declining protection against severe disease,” write the 18 authors, including two FDA regulators who previously announced they would be leaving the agency this fall, per the New York Times.

What does this turn of events mean for people anticipating an extra jab to stave off a breakthrough infection against the highly infectious Delta variant? Here’s what we know so far.

Why did the administration propose boosters, anyway?

According to federal health officials, the plan for extra doses was forged based on available data from the US and around the world, and in the context of surging Delta infections. In a joint statement dated August 18, the US Centers for Disease Control and Prevention (CDC), FDA, and other agency leaders said they were starting to see evidence of waning protection against mild and moderate disease.

“Based on our latest assessment, the current protection against severe disease, hospitalization, and death could diminish in the months ahead, especially among those who are at higher risk or were vaccinated during the earlier phases of the vaccination rollout,” the statement reads. “For that reason, we conclude that a booster shot will be needed to maximize vaccine-induced protection and prolong its durability.”

CDC Director Rochelle Walensky, MD, told reporters at the time that the plan for booster doses was designed to stay ahead of the virus.

Why are scientists questioning the Biden booster plan?

The authors of the Lancet commentary cite a couple of issues. First and foremost, they insist there’s not enough evidence to substantiate boosters for all. And without robust data and analysis to substantiate such a plan, they worry that public confidence in the vaccines could be undermined.

Jaimie Meyer, MD, an infectious disease physician at Yale Medicine, who was not among the contributing authors, agrees that we don’t know enough yet. While there’s some data to suggest that boosters might be needed, it’s not yet clear “for whom the boosters might be most beneficial and exactly when to do them,” says Dr. Meyer.

Statements about a national booster plan “got ahead of the scientific data a little bit,” she tells Health.

Carlos Malvestutto, MD, associate professor in the Division of Infectious Diseases at Ohio State University Wexler Medical Center in Columbus, also agrees with the editorial writers: “I don’t think the evidence exists to support widespread boosting for the entire population.”

Antibody “titers”—meaning the presence and level of antibodies in a vaccinated person’s blood—will wane over time, Dr. Malvestutto explains. However, a decrease in the level of those neutralizing antibodies does not mean there’s a loss of immunity against the virus.

“We actually have really good data showing that memory T cells and B cells, which are very long-lived, actually remain at very high levels,” he tells Health. So, while [data from Israel] show a decrease in antibody levels after six to eight months, he believes “we’re not taking into account the other parts of the immune system that are playing a huge role.”

The US often looks to Israel for insight into how the COVID vaccines will hold up over time. Israel was among the first countries to launch a widespread vaccination program, and therefore serves as a bellwether for vaccine outcomes, according to PolitiFact. It was also the first to start a national booster campaign, per NPR.

But even Israel has implemented a more targeted approach. “Who are they boosting? It’s people 50 and older,” Dr. Malvestrutto points out.

Indeed, many infectious disease doctors say boosters for select groups of individuals may make more sense. Rodney Hood, MD, a San Diego-based internist who chairs the National Medical Association’s COVID-19 Task Force, says older adults, people with comorbidities, and health care workers, for example, “should be eligible soon for booster shots.”

What does this all mean for vaccinated people?

The Biden administration’s proposal contemplates allowing vaccinated people to receive a booster beginning eight months after completing their initial jabs. But that plan is not set in stone.

An FDA advisory committee is scheduled to meet on September 17 to discuss additional doses of COVID-19 vaccines. The committee is considering an application for approval of a third dose of the Pfizer-BioNTech Comirnaty vaccine; It’s unclear when Moderna’s booster shot application will be considered, Reuters reported. And Johnson & Johnson/Janssen continues to study the possibility of a booster dose.

Even if FDA were to grant approval of a Pfizer booster, the CDC’s Advisory Committee on Immunization Practices would still conduct its own review of the evidence and make a recommendation for or against giving booster doses.

Asked to comment on the need for boosters, Kathryn Edwards, MD, a professor of pediatrics in the Division of Infectious Diseases at Vanderbilt University Medical Center in Nashville, simply told Health, “I will await the data that will be presented at the FDA meeting on Friday to make my assessment.”

So stay tuned.

What about people who remain unvaccinated?

That’s one area in which the Biden administration, top scientists, and infectious disease doctors agree: It’s still important for everyone to get their COVID shots.

“Even if some gain can ultimately be obtained from boosting, it will not outweigh the benefits of providing initial protection to the unvaccinated,” the Lancet authors write.


NHS England’s chief executive, Amanda Pritchard, says the test ‘could mark the beginning of a revolution in cancer detection and treatment’. Photograph: NHS England & NHS Improvement/PA

More than 100,000 volunteers aged between 50 and 77 sought to take part in Galleri blood screening

The NHS has launched the world’s largest trial of a potentially gamechanging blood test that aims to detect more than 50 types of cancer before symptoms appear.

More than 100,000 volunteers are being sought to provide blood samples at mobile test clinics in regions across England from Monday to assess how well the test works in the health service.

The Galleri test, which is already available in the US, can find cancers that are difficult to spot early on by picking up fragments of DNA that are shed from tumours into the bloodstream. Among them are cancers of the lung, bowel, pancreas, throat, head and neck.

Blood tests’ development could help the NHS further.

When a tumour is detected at the earliest stage, patients typically have more treatment options and are five to 10 times more likely to survive compared with those detected at stage four, which is the most advanced.

The chief executive of NHS England, Amanda Pritchard, said the quick and simple test “could mark the beginning of a revolution in cancer detection and treatment” and play a major role in the health service’s ambition to catch three-quarters of cancers at an early stage, when they are easier to treat.

The NHS is writing to 140,000 people aged 50 to 77 from different ethnic backgrounds and inviting them to take part in the trial. Participants, who must not have had a cancer diagnosis in the past three years, will be asked to give a first blood sample at a mobile test clinic, and further samples one and two years later.

To find out whether the test helps doctors to identify cancers early, half the trial participants will have their blood samples screened with the Galleri test straight away, while the other half will have their blood stored for potential testing in the future.

Those taking part will be advised to carry on with their usual NHS screening appointments and still contact their GP if they notice any new or unusual symptoms. The small minority who are found to have potential signs of cancer in their blood will be referred to an NHS hospital for further tests.

The trial is being run through eight NHS cancer alliances that cover Cheshire and Merseyside, Cumbria, Greater Manchester, the north-east, the West Midlands, the east Midlands, the east of England, Kent and Medway, and south-east London. If the first results, expected by 2023, are successful, the NHS aims to open the trial to a million more people in 2024 and 2025.

Previous research on tumours at stage one to three found that the Galleri test picked up 67% of a dozen pre-specified cancers that account for about two-thirds of cancer deaths in the UK and the US, and about 41% of all cancers.

“We need to study the Galleri test carefully to find out whether it can significantly reduce the number of cancers diagnosed at a late stage,” said Prof Peter Sasieni, the director of the Cancer Research UK and King’s College London cancer prevention trials unit.

“The test could be a gamechanger for early cancer detection and we are excited to be leading this important research. Cancer screening can find cancers earlier, when they are more likely to be treated successfully, but not all types of screening work.”


%d bloggers like this: